Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | aldo keto reductase | 0.0156 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0156 | 1 | 1 |
Echinococcus granulosus | aldo keto reductase | 0.0156 | 1 | 1 |
Leishmania major | aldehyde reductase, putative,oxidoreductase, putative | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Echinococcus multilocularis | aldo keto reductase | 0.0156 | 1 | 1 |
Trypanosoma cruzi | aldo-keto reductase | 0.0156 | 1 | 0.5 |
Onchocerca volvulus | 0.0156 | 1 | 0.5 | |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0156 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Entamoeba histolytica | aldose reductase, putative | 0.0156 | 1 | 0.5 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0156 | 1 | 1 |
Mycobacterium ulcerans | oxidoreductase | 0.0156 | 1 | 0.5 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Giardia lamblia | Aldose reductase | 0.0156 | 1 | 0.5 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0156 | 1 | 1 |
Entamoeba histolytica | aldose reductase, putative | 0.0156 | 1 | 0.5 |
Mycobacterium leprae | PROBABLE OXIDOREDUCTASE | 0.0156 | 1 | 1 |
Giardia lamblia | Aldose reductase | 0.0156 | 1 | 0.5 |
Onchocerca volvulus | 0.0156 | 1 | 0.5 | |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0156 | 1 | 1 |
Toxoplasma gondii | aldose reductase, putative | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Entamoeba histolytica | aldose reductase, putative | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Schistosoma mansoni | aldo-keto reductase | 0.0156 | 1 | 0.5 |
Loa Loa (eye worm) | oxidoreductase | 0.0156 | 1 | 0.5 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0156 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0156 | 1 | 0.5 |
Echinococcus multilocularis | aldo keto reductase | 0.0156 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0156 | 1 | 0.5 |
Leishmania major | prostaglandin f2-alpha synthase/D-arabinose dehydrogenase | 0.0156 | 1 | 0.5 |
Onchocerca volvulus | 0.0156 | 1 | 0.5 | |
Echinococcus granulosus | aldo keto reductase | 0.0156 | 1 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0156 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0156 | 1 | 0.5 |
Echinococcus multilocularis | aldo keto reductase | 0.0156 | 1 | 1 |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Onchocerca volvulus | 0.0156 | 1 | 0.5 | |
Schistosoma mansoni | pol-related | 0.0156 | 1 | 0.5 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0156 | 1 | 0.5 |
Trypanosoma brucei | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0156 | 1 | 1 |
Trypanosoma brucei | prostaglandin f synthase | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo/keto reductase, putative | 0.0156 | 1 | 0.5 |
Schistosoma mansoni | aldo-keto reductase | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Echinococcus granulosus | aldo keto reductase | 0.0156 | 1 | 1 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Loa Loa (eye worm) | oxidoreductase | 0.0156 | 1 | 0.5 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0156 | 1 | 1 |
Onchocerca volvulus | 0.0156 | 1 | 0.5 | |
Trichomonas vaginalis | dihydrodiol dehydrogenase, putative | 0.0156 | 1 | 0.5 |
Echinococcus multilocularis | aldo keto reductase family 1, member B4 | 0.0156 | 1 | 1 |
Onchocerca volvulus | 0.0156 | 1 | 0.5 | |
Leishmania major | prostaglandin f synthase, putative | 0.0156 | 1 | 0.5 |
Loa Loa (eye worm) | oxidoreductase | 0.0156 | 1 | 0.5 |
Echinococcus granulosus | aldo keto reductase family 1 member B4 | 0.0156 | 1 | 1 |
Echinococcus granulosus | hypothetical protein | 0.0156 | 1 | 1 |
Brugia malayi | oxidoreductase, aldo/keto reductase family protein | 0.0156 | 1 | 0.5 |
Leishmania major | aldo-keto reductase-like protein | 0.0156 | 1 | 0.5 |
Trichomonas vaginalis | aldo-keto reductase, putative | 0.0156 | 1 | 0.5 |
Loa Loa (eye worm) | oxidoreductase | 0.0156 | 1 | 0.5 |
Trypanosoma cruzi | aldo/keto reductase, putative | 0.0156 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = -2.05 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = -1.54 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 0 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 0.55 % | ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro | ChEMBL. | No reference |
Inhibition (functional) | = 1 % | GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM. | ChEMBL. | 20485427 |
Inhibition (functional) | = 32 % | GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition (functional) | = 92 % | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM | ChEMBL. | 20485427 |
Inhibition frequency index (IFI) (functional) | = 0 | Inhibition Frequency Index (IFI) | GSK. | 20485427 |
Percent growth inhibition (functional) | = -2 % | Percent inhibition of P. falciparum lactate dehydrogenase activity (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 1 % | Percent inhibition of HepG2 growth (at 10 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 32 % | Percent inhibition of P. falciparum Dd2 growth (at 2 uM) | GSK. | 20485427 |
Percent growth inhibition (functional) | = 92 % | Percent inhibition of P. falciparum 3D7 growth (at 2 uM) | GSK. | 20485427 |
XC50 (functional) | = 6.24 | XC50 determination of P. falciparum 3D7 growth | GSK. | 20485427 |
XC50 (functional) | = 0.56926 uM | GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth. | ChEMBL. | 20485427 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.